Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials. - Lenz G; Tilly H; Ziepert M; Altmann B; Herbaux C; Frontzek F; Nickelsen M; Lee C; Hirata J; Sahin D; Chohan S; Batlevi CL; et al. (Leukemia, 2024)